Display options
Cite
Zhang X, Luo W, Zhao W, et al. Isocryptotanshinone Induced Apoptosis and Activated MAPK Signaling in Human Breast Cancer MCF-7 Cells. J Breast Cancer. 2015;18(2):112-8doi: 10.4048/jbc.2015.18.2.112.
Zhang, X., Luo, W., Zhao, W., Lu, J., & Chen, X. (2015). Isocryptotanshinone Induced Apoptosis and Activated MAPK Signaling in Human Breast Cancer MCF-7 Cells. Journal of breast cancer, 18(2), 112-8. https://doi.org/10.4048/jbc.2015.18.2.112
Zhang, Xuenong, et al. "Isocryptotanshinone Induced Apoptosis and Activated MAPK Signaling in Human Breast Cancer MCF-7 Cells." Journal of breast cancer vol. 18,2 (2015): 112-8. doi: https://doi.org/10.4048/jbc.2015.18.2.112
Zhang X, Luo W, Zhao W, Lu J, Chen X. Isocryptotanshinone Induced Apoptosis and Activated MAPK Signaling in Human Breast Cancer MCF-7 Cells. J Breast Cancer. 2015 Jun;18(2):112-8. doi: 10.4048/jbc.2015.18.2.112. Epub 2015 Jun 26. PMID: 26155286; PMCID: PMC4490259.
Copy Download .nbib Format: NLM
Share it on

J Breast Cancer. 2015 Jun;18(2):112-8. doi: 10.4048/jbc.2015.18.2.112. Epub 2015 Jun 26.

Isocryptotanshinone Induced Apoptosis and Activated MAPK Signaling in Human Breast Cancer MCF-7 Cells.

Journal of breast cancer

Xuenong Zhang, Weiwei Luo, Wenwen Zhao, Jinjian Lu, Xiuping Chen

Affiliations

  1. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.

PMID: 26155286 PMCID: PMC4490259 DOI: 10.4048/jbc.2015.18.2.112

Abstract

PURPOSE: Isocryptotanshinone (ICTS) is a natural bioactive product that is isolated from the roots of the widely used medical herb Salvia miltiorrhiza. However, few reports exist on the mechanisms underlying the therapeutic effects of ICTS. Here, we report that ICTS has anticancer activity and describe the mechanism underlying this effect.

METHODS: The antiproliferative effect of ICTS was determined using 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) and clonogenic assays. The effect of ICTS on the cell cycle was measured using flow cytometry. Apoptosis was determined by Hoechst 33342 staining, DNA fragmentation assays, and Western blotting for apoptotic proteins. Finally, the effect of ICTS on mitogen-activated protein kinases (MAPKs) was determined by Western blotting.

RESULTS: ICTS significantly inhibited proliferation of MCF-7 and MDA-MB-231 human breast cancer cells, HepG2 human liver cancer cells, and A549 human lung cancer cells in vitro. Among the tested cell lines, MCF-7 cells showed the highest sensitivity to ICTS. ICTS significantly inhibited colony formation by MCF-7 cells. Furthermore, exposure of MCF-7 cells to ICTS induced cell cycle arrest at the G1 phase and decreased mitochondrial membrane potential. Hoechst 33342 staining and Western blot analysis for apoptotic proteins suggested that ICTS induced apoptosis in MCF-7 cells. In addition, ICTS activated MAPK signaling in MCF-7 cells by inducing time- and concentration-dependent phosphorylation of JNK, ERK, and p38 MAPK.

CONCLUSION: Our results suggest that ICTS inhibited MCF-7 cell proliferation by inducing apoptosis and activating MAPK signaling pathways.

Keywords: Apoptosis; Breast neoplasms; Isocryptotanshinone; Mitogen-activated protein kinases

References

  1. Mol Med Rep. 2010 Jul-Aug;3(4):645-50 - PubMed
  2. Cancer Prev Res (Phila). 2012 May;5(5):778-87 - PubMed
  3. Mol Med Rep. 2014 Jun;9(6):2447-52 - PubMed
  4. Cancer Chemother Pharmacol. 2011 Jul;68(1):17-27 - PubMed
  5. J Clin Exp Dent. 2014 Feb 01;6(1):e81-90 - PubMed
  6. Food Chem Toxicol. 2013 Oct;60:147-52 - PubMed
  7. Chin Med. 2011 Jul 22;6(1):27 - PubMed
  8. Oncogene. 2003 Nov 24;22(53):8590-607 - PubMed
  9. Mol Cancer Ther. 2011 Jan;10(1):57-68 - PubMed
  10. Cancer Lett. 2007 Jan 8;245(1-2):269-74 - PubMed
  11. Biol Pharm Bull. 2005 Sep;28(9):1795-7 - PubMed
  12. Cancer Res. 2009 Jan 1;69(1):193-202 - PubMed
  13. Cancer Lett. 2009 Nov 18;285(1):46-57 - PubMed
  14. Int J Oncol. 2008 Sep;33(3):485-91 - PubMed
  15. Apoptosis. 2014 Apr;19(4):615-28 - PubMed
  16. Mol Cell Biochem. 2011 May;351(1-2):41-58 - PubMed
  17. Apoptosis. 2012 Mar;17 (3):248-57 - PubMed
  18. Int J Mol Sci. 2012 Oct 22;13(10):13621-66 - PubMed
  19. Asian Pac J Cancer Prev. 2014;15(6):2439-45 - PubMed
  20. Cancer Lett. 2014 Mar 28;344(2):174-9 - PubMed
  21. Eur J Pharmacol. 2013 Aug 15;714(1-3):239-48 - PubMed
  22. Mol Cell Biochem. 2012 Sep;368(1-2):17-25 - PubMed
  23. Mol Cell Biochem. 2013 Sep;381(1-2):273-82 - PubMed
  24. Cancer Lett. 2010 Dec 1;298(1):88-98 - PubMed
  25. Oncol Rep. 2011 Mar;25(3):781-8 - PubMed
  26. Int J Oncol. 2011 Dec;39(6):1567-75 - PubMed
  27. Med Res Rev. 2014 Jul;34(4):768-94 - PubMed
  28. J Natl Cancer Inst. 2013 May 1;105(9):643-53 - PubMed
  29. Apoptosis. 2007 May;12(5):835-40 - PubMed

Publication Types